Hexagon Bio

Hexagon Bio is a biopharmaceutical company based in Menlo Park, California, founded in 2016.

The company focuses on discovering novel payloads for antibody-drug conjugates (ADCs) to meet critical needs in oncology. Hexagon Bio utilizes a proprietary platform that integrates data science, genomics, synthetic biology, chemistry, and automation to identify small molecules and their protein targets from microbial genomes. The company is advancing a pipeline of next-generation ADC candidates aimed at treating various solid tumors and hematological malignancies. Hexagon Bio also engages in drug discovery and early-stage development, licensing its candidates to larger pharmaceutical companies for further development and commercialization. In addition to its oncology focus, Hexagon Bio has expanded its reach into the agricultural sector through a joint venture with Corteva, aimed at developing nature-inspired crop protection solutions. The company has raised significant funding to support its initiatives and employs around 82 people.